Efficacy of Clonidine Adhesive Patch for Patients With Tourette Syndrome: A Randomized, Double-blind, Placebo-Controlled, Multicenter Clinical Trial
Larger doses of the clonidine adhesive patch such as 1.5 and 2.0 mg/wk are effective in improving the symptoms and overall function of participants with TS.
Authors
- Yasong Du (ORCID: https://orcid.org/0000-0002-9937-8438)
- Suzhen Sun (ORCID: https://orcid.org/0000-0001-8075-9137)
- Zhimin Zhao (ORCID: https://orcid.org/0009-0000-8956-8804)
- Fuyong Jiao
- Yun Qian
- Huimei Wang (ORCID: https://orcid.org/0000-0002-0726-2850)
- Jie He (ORCID: https://orcid.org/0000-0002-5880-8112)
- Yanhui Chen (ORCID: https://orcid.org/0000-0002-8905-3154)
- Xiuxia Wang
- Jianning Mai
- Hong Chen (ORCID: https://orcid.org/0009-0007-7107-1374)
Institutions
- Hebei Medical University (CN)
- Shanxi Medical University (CN)
- Dalian Medical University (CN)
- Shanghai Mental Health Center (CN)
- Hospital of Hebei Province (CN)
- China National Pharmaceutical Group Corporation (China) (CN)
- Second Hospital of Hebei Medical University (CN)
- Guangzhou Women and Children Medical Center (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Shanxi Provincial Children's Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
- Union Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/wnf.0000000000000605
- Citations
- 2
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.28